Skip to main content

Venatorx Pharmaceuticals

Malvern, United States

Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.

$24.7M raised
Sep 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Venatorx Pharmaceuticals

How much funding has Venatorx Pharmaceuticals raised?
Venatorx Pharmaceuticals has raised $24.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.
Who are Venatorx Pharmaceuticals's investors?
Venatorx Pharmaceuticals's investors include Abingworth, Foresite Capital, BioAdvance, Wellcome Trust, Versant Ventures.
Where is Venatorx Pharmaceuticals headquartered?
Venatorx Pharmaceuticals is headquartered in Malvern, United States.
What does Venatorx Pharmaceuticals do?
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
What stage is Venatorx Pharmaceuticals at?
Venatorx Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Venatorx Pharmaceuticals — Funding & Investors." VCBacked, September 2, 2022, https://www.vcbacked.co/company/venatorx-pharmaceuticals. Accessed July 4, 2026.
APA
VCBacked. (2022). Venatorx Pharmaceuticals — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/venatorx-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Venatorx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/venatorx-pharmaceuticals |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .